[{"NetIncomeLoss_1_Q3_USD":-18841000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q3_shares":26663968.0,"CommitmentsAndContingencies_0_Q3_USD":null,"AccruedLiabilitiesCurrent_0_Q3_USD":3147000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_0_Q3_USD":25.71,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_0_Q3_USD":255625000.0,"AccountsPayableRelatedPartiesCurrent_0_Q3_USD":0.0,"NetCashProvidedByUsedInInvestingActivities_3_Q3_USD":-119311000.0,"PaymentsToAcquireInvestments_3_Q3_USD":263974000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_3_Q3_shares":893250.0,"DividendsCommonStockCash_3_Q3_USD":0.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearThree_0_Q3_USD":949000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_3_Q3_shares":26298969.0,"AssetsCurrent_0_Q3_USD":361220000.0,"StockIssuedDuringPeriodValueStockOptionsExercised_1_Q3_USD":680000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_0_Q3_USD":1001000.0,"CommonStockSharesIssued_0_Q3_shares":26787816.0,"Assets_0_Q3_USD":364436000.0,"ShareBasedCompensation_3_Q3_USD":9004000.0,"OperatingLeaseRightOfUseAsset_0_Q3_USD":2604000.0,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_3_Q3_USD":21.77,"PreferredStockParOrStatedValuePerShare_0_Q3_USD":0.0001,"CommonStockParOrStatedValuePerShare_0_Q3_USD":0.0001,"LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_0_Q3_USD":289000.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_3_Q3_USD":12609000.0,"AociBeforeTaxAttributableToParent_0_Q3_USD":370000.0,"GeneralAndAdministrativeExpense_1_Q3_USD":6944000.0,"GeneralAndAdministrativeExpense_3_Q3_USD":19585000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_0_Q3_USD":10.2,"LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_0_Q3_USD":242000.0,"ResearchAndDevelopmentExpense_3_Q3_USD":27824000.0,"ResearchAndDevelopmentExpense_1_Q3_USD":12585000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_0_Q3_USD":25.71,"LesseeOperatingLeaseLiabilityPaymentsDue_0_Q3_USD":3174000.0,"ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities_3_Q3_USD":145000000.0,"IncreaseDecreaseInAccruedLiabilities_3_Q3_USD":794000.0,"CommonStockValue_0_Q3_USD":3000.0,"InvestmentIncomeNet_3_Q3_USD":2864000.0,"InvestmentIncomeNet_1_Q3_USD":688000.0,"DepreciationDepletionAndAmortization_3_Q3_USD":97000.0,"NetCashProvidedByUsedInFinancingActivities_3_Q3_USD":2114000.0,"RestrictedCash_0_Q3_USD":157000.0,"PaymentsOfStockIssuanceCosts_3_Q3_USD":439000.0,"OtherAssetsCurrent_0_Q3_USD":262000.0,"ComprehensiveIncomeNetOfTax_3_Q3_USD":-44180000.0,"ComprehensiveIncomeNetOfTax_1_Q3_USD":-19368000.0,"IncreaseDecreaseInAccountsPayable_3_Q3_USD":578000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q3_USD":44787000.0,"OperatingLeaseLiabilityNoncurrent_0_Q3_USD":2058000.0,"AdditionalPaidInCapitalCommonStock_0_Q3_USD":476943000.0,"Liabilities_0_Q3_USD":7177000.0,"DefinedContributionPlanCostRecognized_3_Q3_USD":200000.0,"OperatingLeaseLiability_0_Q3_USD":2885000.0,"PreferredStockSharesOutstanding_0_Q3_shares":0.0,"CommonStockSharesAuthorized_0_Q3_shares":150000000.0,"LitigationReserve_0_Q3_USD":0.0,"OperatingIncomeLoss_3_Q3_USD":-47409000.0,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_3_Q3_USD":92.62,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_0_Q3_shares":4676732.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_3_Q3_USD":-44545000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1_Q3_USD":-18841000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q3_USD":4144000.0,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":-46911000.0,"LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_0_Q3_USD":982000.0,"LiabilitiesCurrent_0_Q3_USD":5119000.0,"AccountsPayableCurrent_0_Q3_USD":1145000.0,"NonoperatingIncomeExpense_3_Q3_USD":2864000.0,"NonoperatingIncomeExpense_1_Q3_USD":688000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q3_USD":15918000.0,"CommonStockSharesOutstanding_0_Q3_shares":26787816.0,"ProceedsFromStockOptionsExercised_3_Q3_USD":2553000.0,"OperatingLeaseWeightedAverageDiscountRatePercent_0_Q3_pure":0.0621,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_0_Q3_USD":255625000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_0_Q3_USD":44944000.0,"OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentBeforeTaxPortionAttributableToParent_3_Q3_USD":365000.0,"OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentBeforeTaxPortionAttributableToParent_1_Q3_USD":-527000.0,"StockIssuedDuringPeriodSharesStockOptionsExercised_3_Q3_shares":775062.0,"OperatingLeasePayments_3_Q3_USD":491000.0,"PrepaidInsurance_0_Q3_USD":3165000.0,"SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_0_Q3_USD":199073000.0,"PropertyPlantAndEquipmentNet_0_Q3_USD":455000.0,"NetIncomeLoss_3_Q3_USD":-44545000.0,"OtherAccruedLiabilitiesCurrent_0_Q3_USD":187000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_3_Q3_USD":-164108000.0,"MarketableSecurities_0_Q3_USD":300110000.0,"LeaseCost_3_Q3_USD":564000.0,"PreferredStockValue_0_Q3_USD":null,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_3_Q3_USD":3.29,"OperatingLeaseCost_3_Q3_USD":564000.0,"LiabilitiesAndStockholdersEquity_0_Q3_USD":364436000.0,"EmployeeRelatedLiabilitiesCurrent_0_Q3_USD":1559000.0,"PreferredStockSharesAuthorized_0_Q3_shares":10000000.0,"DerivativeLiabilities_0_Q3_USD":0.0,"AllocatedShareBasedCompensationExpense_3_Q3_USD":9004000.0,"AllocatedShareBasedCompensationExpense_1_Q3_USD":4144000.0,"EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_0_Q3_USD":43200000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_3_Q3_shares":56000.0,"OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent_1_Q3_USD":-527000.0,"OperatingLeaseLiabilityCurrent_0_Q3_USD":827000.0,"OperatingExpenses_3_Q3_USD":47409000.0,"OperatingExpenses_1_Q3_USD":19529000.0,"RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_3_Q3_USD":3259000.0,"EarningsPerShareBasicAndDiluted_3_Q3_USD":-1.69,"EarningsPerShareBasicAndDiluted_1_Q3_USD":-0.71,"ProfitLoss_3_Q3_USD":-44545000.0,"DeferredOfferingCosts_0_Q3_USD":405000.0,"StockholdersEquity_0_Q3_USD":357259000.0,"PaymentsToAcquirePropertyPlantAndEquipment_3_Q3_USD":337000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_0_Q3_shares":4676732.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_0_Q3_shares":2965410.0,"RetainedEarningsAccumulatedDeficit_0_Q3_USD":-120057000.0,"OperatingIncomeLoss_1_Q3_USD":-19529000.0,"AccruedProfessionalFeesCurrent_0_Q3_USD":273000.0,"Ticker":"KRTX","CIK":"1771917","name":"KARUNA THERAPEUTICS, INC.","OfficialName":"Karuna Therapeutics Inc. Common Stock","form":"10-Q","period":"20200930","fy":"2020.0","fp":"Q3","qtrs":"1","uom":"USD","footnote":"nan","Market Cap":"3925750608.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20201105"}]